KMTS — Kestra Medical Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- $1.70bn
- $1.57bn
- $95.13m
Annual cashflow statement for Kestra Medical Technologies, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2021 April 30th | 2023 April 30th | 2024 April 30th | 2025 April 30th | 2026 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -34.1 | -84.2 | -94.1 | -114 | -132 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 3.81 | 8.49 | 5.92 | 34.4 | 39.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.019 | 1.3 | 4.39 | -6.2 | 1.78 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -29.9 | -69.6 | -72.2 | -77.6 | -81.7 |
| Capital Expenditures | -0.336 | -13.9 | -12.2 | -22.9 | -34.9 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.002 | -1.53 | -0.003 | -0.372 | -168 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.334 | -15.5 | -12.2 | -23.3 | -203 |
| Financing Cash Flow Items | 18.5 | -0.671 | 41.8 | 8.7 | -2.79 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 48.8 | 96.1 | 77.7 | 330 | 147 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 18.6 | 11 | -6.74 | 229 | -138 |